(Q54333542)
Statements
The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience. (English)
Irit Avivi
Emilia Hardak
Ilana Oren
Eldad J Dann
Mordechai Yigla
Tal Faibish
Jacob M Rowe
16 December 2011
127
2
110-114
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference